Advertisement

Obesity Surgery

, Volume 28, Issue 4, pp 1025–1030 | Cite as

The Factors Affecting Lower Urinary Tract Functions in Patients Undergoing Laparoscopic Sleeve Gastrectomy

  • Haci Murat Cayci
  • Sedat Oner
  • Umut Eren Erdogdu
  • İdris Nas
  • Evren Dilektasli
  • Murat Demirbas
Original Contributions

Abstract

Background

We prospectively assessed changes in the lower urinary system functions of women with morbid obesity following laparoscopic sleeve gastrectomy and the factors affecting these changes.

Methods

Data from 40 females who had undergone laparoscopic sleeve gastrectomy due to morbid obesity (body mass index, BMI ≥ 40 kg/m2) between January 2014–2016 at S.B.U. Bursa Yuksek Ihtisas Training and Research Hospital were prospectively evaluated. The presence of comorbidities, onset of obesity, smoking, American Society of Anesthesiologists (ASA) score, pre and 12-month postoperative weights and BMIs, fasting blood glucose (FBG), blood urea nitrogen, creatinine, insulin, homeostatic model assessment-insulin resistance (HOMA-IR) test results, overactive bladder survey (OAB-Q) scores, volume of urination, and Qmax values obtained from uroflowmetry studies were recorded and assessed.

Results

Statistically significant differences in weight, BMI, FBG, insulin, HOMA-IR score and creatinine values pre-operation, and the corresponding values obtained at 12 months post-operation were observed (all, p < 0.001). OAB-Q scores were observed to be statistically significantly lower in the postoperative period relative to those in the preoperative period (p < 0.001). Urination volume was statistically significantly higher during the postoperative period (p = 0.048) than during the preoperative period. Non-smoking patients showed a reduction in OAB-Q score and a statistically significant increase in urination volume during the postoperative period (p < 0.001, p = 0.011, respectively); smoking patients indicated a statistically significant reduction in OAB-Q score only during the postoperative period; however, urination volume was not statistically significant between two groups (p = 0.013, p = 0.303). In patients with an ASA score of 1, preoperative OAB-Q scores were statistically significantly lower (p = 0.035) than those obtained post-operation. Patients with childhood-onset obesity showed statistically significantly increased urination volumes during postoperative period in comparison with values obtained pre-operation (p = 0.042).

Conclusion

Improvements in lower urinary system functions were affected by patient-related factors, such as comorbidity, obesity onset, smoking, ASA score, and weight loss, following laparoscopic sleeve gastrectomy.

Keywords

Morbid obesity Laparoscopic sleeve gastrectomy Lower urinary system functions 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Prospective Studies Collaboration, Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.CrossRefPubMedGoogle Scholar
  3. 3.
    Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308(11):1122–31.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.CrossRefPubMedGoogle Scholar
  5. 5.
    Kristal AR, Arnold KB, Schenk JM, et al. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol. 2007;177(4):1395–400.CrossRefPubMedGoogle Scholar
  6. 6.
    Mondul AM, Giovannucci E, Platz EAA. Prospective study of obesity and incidence and progression of lower urinary tract symptoms. J Urol. 2014;191(3):715–21.CrossRefPubMedGoogle Scholar
  7. 7.
    Penson DF, Munro HM, Signorello LB, et al. Urologic diseases in America project. Obesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort Study. J Urol. 2011;186(6):2316–22.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kastarinen M, Juutilainen A, Kastarinen H, et al. Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland. J Intern Med. 2010;267(6):612–20.CrossRefPubMedGoogle Scholar
  9. 9.
    Elia G, Dye TD, Scariati PD. Body mass index and urinary symptoms in women. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(6):366–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Uustal Fornell E, Wingren G, Kjolhede P. Factors associated with pelvic floor dysfunction with emphasis on urinary and fecal incontinence and genital prolapse: an epidemiological study. Acta Obstet Gynecol Scand. 2004;83(4):383–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Richter HE, Burgio KL, Clements RH, et al. Urinary and anal incontinence in morbidly obese women considering weight loss surgery. Obstet Gynecol. 2005;106(6):1272–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Fenner DE, Trowbridge ER, Patel DA, et al. Establishing the prevalence of incontinence study: racial differences in women’s patterns of urinary incontinence. J Urol. 2008;179(4):1455–60.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Abrams P, Cardozo L, Fall M, et al. Standardisation Sub-Committee of the International Continence Society. The standardization of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49.CrossRefPubMedGoogle Scholar
  14. 14.
    Palleschi G, Pastore AL, Rizzello M, et al. Laparoscopic sleeve gastrectomy effects on overactive bladder symptoms. J Surg Res. 2015;196(2):307–12.CrossRefPubMedGoogle Scholar
  15. 15.
    Fenster CP, Weinsier RL, Darley-Usmar VM, et al. Obesity, aerobic exercise, and vascular disease: the role of oxidant stress. Obes Res. 2002;10(9):964–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Tong RS, Larner T, Finlay M, et al. Pelvic lipomatosis associated with proliferative cystitis occurring in two brothers. Urology. 2002;59(4):602.CrossRefPubMedGoogle Scholar
  17. 17.
    Blaivas JG, Panagopoulos G, Weiss JP, et al. Validation of the overactive bladder symptom score. J Urol. 2007;178(2):543–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Mondul AM, Giovannucci E, Platz EAA. Prospective study of obesity, and the incidence and progression of lower urinary tract symptoms. J Urol. 2014;191(3):715–21.CrossRefPubMedGoogle Scholar
  19. 19.
    Engeli S, Sharma AM. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med. 2001;79(1):21–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Sharma AM, Engeli S, Pischon T. New developments in mechanisms of obesity-induced hypertension: role of adipose tissue. Curr Hypertens Rep. 2001;3(2):152–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Bomback AS, Klemmer PJ. Interaction of aldosterone and extracellular volume in the pathogenesis of obesity associated kidney disease: a narrative review. Am J Nephrol. 2009;30(2):140–6.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Morandi A, Maffeis C. Urogenital complications of obesity. Best Pract Clin Res Endocr Metabol. 2013;27(2):209–18.CrossRefGoogle Scholar
  23. 23.
    Whitcomb EL, Lukacz ES, Lawrence JM, et al. Prevalence and degree of bother from pelvic floor disorders in obese women. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(3):289–94.CrossRefPubMedGoogle Scholar
  24. 24.
    Khullar V, Sexton CC, Thompson CL, et al. The relationship between BMI and urinary incontinence subgroups: results from EpiLUTS. Neurourol Urodyn. 2014;33(4):392–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Whitcomb EL, Subak LL. Effect of weight loss on urinary incontinence in women. Open Access J Urol. 2011;3:123–32.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Pashootan P, Ploussard G, Cocaul A, et al. Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort. BJU Int. 2015;116(1):124–30.CrossRefPubMedGoogle Scholar
  27. 27.
    McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int. 2006;97(Suppl 2):23–8. discussion 44-5CrossRefPubMedGoogle Scholar
  28. 28.
    McGrother CW, Donaldson MM, Thompson J, et al. Etiology of overactive bladder: a diet and lifestyle model for diabetes and obesity in older women. Neurourol Urodyn. 2012;31(4):487–95.CrossRefPubMedGoogle Scholar
  29. 29.
    Gharaee-Kermani M, Rodriguez-Nieves JA, Mehra R, et al. Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model. Prostate. 2013;73(10):1123–33.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Dilektasli E, Erol MF, Cayci HM, et al. Low educational status and childhood obesity associated with insufficient mid-term weight loss after sleeve gastrectomy: a retrospective observational cohort study. Obes Surg. 2017;27(1):162–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Tähtinen RM, Auvinen A, Cartwright R, et al. Smoking and bladder symptoms in women. Obstet Gynecol. 2011;118(3):643–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Bump RC, McClish DM. Cigarette smoking and pure genuine stress incontinence of urine: a comparison of risk factors and terminants between smokers and non-smokers. Am J Obstet Gynecol. 1994;171(579):82.Google Scholar
  33. 33.
    Finucane MM, Stevens GA, Cowan MJ, et al. Global burden of metabolic risk factors of chronic diseases collaborating group (body mass index). National, regional, and global trends in bodymass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–67.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Trastulli S, Desiderio J, Guarino S, et al. Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials. Surg Obes Relat Dis. 2013;9(5):816–29.CrossRefPubMedGoogle Scholar
  35. 35.
    Peluso L, Vanek VW. Efficacy of gastric bypass in the treatment of obesity-related comorbidities. Nutr Clin Pract. 2007;22(1):22–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Haci Murat Cayci
    • 1
  • Sedat Oner
    • 2
  • Umut Eren Erdogdu
    • 1
  • İdris Nas
    • 2
  • Evren Dilektasli
    • 1
  • Murat Demirbas
    • 2
  1. 1.Department of General Surgery, Bursa Yuksek Ihtisas Teaching and Research HosiptalBursaTurkey
  2. 2.Department of UrologyBursa Yuksek Ihtisas Teaching and Research HospitalBursaTurkey

Personalised recommendations